Skip to main content
Premium Trial:

Request an Annual Quote

Acacia, CombiMatrix


Acacia subsidiary CombiMatrix has created what is believed to be the first microarray based on the Severe Acute Respiratory Syndrome coronavirus, the company said.

CombiMatrix said the arrays were fabricated “within 48 hours” of publication of the coronavirus genome sequence believed to be responsible for SARS. Researchers at the US Centers for Disease Control and at the Michael Smith Genome Sciences Center in Canada independently announced early this week that they had sequenced the coronavirus genome.


Filed under

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.